Physician profile

Thomas M Moshiri

Interventional Pain Medicine · Phoenix, AZ

NPI 1487628442

$18,997.94

in general payments reported to CMS, 2019-2025

12 companies · $7,267 in 2025

The $7,267 reported for 2025 was more than what 93% of Interventional Pain Medicine providers received nationally (typical 2025 total: $676).

See the full distribution for Interventional Pain Medicine

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$8,972.03
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program$5,707.50
Consulting Fee$1,912.50
Travel and Lodging$1,369.42
Debt Forgiveness$136.85

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Abbott Laboratories $9,480.82 2024-2025 Proclaim, Octrode, Eterna
Globus Medical, INC. $2,631.34 2025 Senza, Corridor, Omnia
Nevro Corp. $2,421.10 2019-2024 Senza
Nalu Medical, INC. $1,441.46 2023-2025 Nalu Neurostimulation System
Boston Scientific Corporation $1,403.81 2019-2025 General - Pain Management, Superion Indirect Decompression System, Wavewriter Alpha Prime 16
Saluda Medical Americas, INC. $571.39 2024-2025 Evoke
Vertos Medical, INC. $409.40 2019-2024 Mild Device Kit
Stryker Corporation $267.79 2024-2025 Spinejack, Optablate, Mild Device Kit
Merit Medical Systems INC $136.85 2023
Medtronic, INC. $109.26 2025 Kyphon Express II Kyphopak Tray
Foundation Fusion Solutions, LLC $63.40 2025
Nuvasive, INC. $61.32 2019

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Thomas M Moshiri

$18,997.94

in general payments reported 2019-2025

Years
2019-2025
Top company
Abbott Laboratories
Context
The $7,267 reported for 2025 was more than what 93% of Interventional Pain Medicine providers received nationally (typical 2025 total: $676).

https://glasscript.com/doctor/775759/thomas-m-moshiri

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.